T1	Participants 10 85	rheumatoid arthritis patients of Shen deficiency and cold invading syndrome
T2	Participants 328 353	rheumatoid arthritis (RA)
T3	Participants 423 515	RA patients of Shen deficiency and cold invading syndrome in the treatment group (120 cases)
T4	Participants 580 605	control group (120 cases)
